Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$12.4B
sum of reported positions
Reported positions
747
Changes vs prior quarter
730
74 new · 101 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 248 measured positions in 8 quarters, the typical new or larger position finished −0.1 pts against the S&P 500 and 50% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 994K | $144M | 1.2% | |
| 860K | $137M | 1.1% | |
| 262K | $116M | 0.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.1B | $12.4B |
| Positions | 774 | 747 |
| Biggest line | — | Arcosa, Inc. 1% |
| 788K |
| $114M |
| 0.9% |
| 824K | $112M | 0.9% |
| 149K | $109M | 0.9% |
| 286K | $108M | 0.9% |
| 864K | $96.7M | 0.8% |
| 666K | $95M | 0.8% |
| 1.93M | $92.2M | 0.7% |
| 1.05M | $92.1M | 0.7% |
| 262K | $91.8M | 0.7% |
| 3.29M | $86M | 0.7% |
| 866K | $85.4M | 0.7% |
| 1.06M | $84.9M | 0.7% |
| 266K | $83.5M | 0.7% |
| 1.33M | $82.8M | 0.7% |
| 213K | $80.4M | 0.6% |
| 1.32M | $77.7M | 0.6% |
| 842K | $76.4M | 0.6% |
| 1.91M | $75.7M | 0.6% |
| 824K | $74.7M | 0.6% |
| 114K | $73.2M | 0.6% |
| 940K | $70.2M | 0.6% |
| 938K | $69.3M | 0.6% |
Burke & Herbert Financial Services (BHRB)
59K → 55K shares (−7%)
Compass Pathways (CMPS)
382K → 267K shares (−30%)
Axogen (AXGN)
114K → 73K shares (−36%)
Cae (CAE)
198K → 133K shares (−33%)
PHINIA, Inc. (PHIN)
41K → 40K shares (−2%)
Royal Gold (RGLD)
22K → 16K shares (−29%)
Benchmark Electronics, Inc. (BHE)
38K → 31K shares (−16%)
Bridgebio Oncology Therapeutics (BBOT)
637K → 385K shares (−40%)
Compass Therapeutics (CMPX)
1.62M → 1.34M shares (−18%)
Smartrent (SMRT)
2.62M → 2.37M shares (−10%)
Lifemd (LFMD)
1.2M → 636K shares (−47%)
Golar LNG (GLNG)
55K → 49K shares (−10%)
Brightstar Lottery (BRSL)
2.41M → 219K shares (−91%)
Westamerica Bank (WABC)
43K → 39K shares (−8%)
NETSCOUT Systems, Inc. (NTCT)
53K → 52K shares (−2%)
Univest Financial (UVSP)
54K → 51K shares (−6%)
Cohen & Steers, Inc. (CNS)
31K → 28K shares (−8%)
MasterBrand, Inc. (MBC)
236K → 209K shares (−11%)
Redwire (RDW)
225K → 170K shares (−24%)
Siga Technologies (SIGA)
668K → 551K shares (−18%)
World Acceptance Corporation (WRLD)
9,814 → 8,697 shares (−11%)
Acadian Asset Management Inc. (AAMI)
32K → 27K shares (−17%)
S&T Bancorp, Inc. (STBA)
42K → 39K shares (−8%)
Freeport-McMoRan (FCX)
45K → 30K shares (−33%)
Teradata (TDC)
58K → 54K shares (−8%)